Prefilled Syringes Market to Grow at 3.9% Annually, Predicts Roots Analysis

Roots Analysis has announced the addition of the “Prefilled Syringes Market (4th Edition), 2017-2026” report to its list of offerings. The report provides a comprehensive analysis of the current state and the likely future evolution of the prefilled syringes market. It provides details... - January 08, 2017

Viral Vectors and Plasmid DNA Manufacturing to Witness 16% Annual Growth, Predicts Roots Analysis

Roots Analysis has announced the addition of the “Viral Vectors and Plasmid DNA Manufacturing Market, 2016-2026” report to its portfolio. The report features an extensive study of the rapidly growing market of gene therapy vectors. Kashish Goel, the principal analyst, said, “Gene... - November 02, 2016

Smart Wearables: The Future of Personalized Healthcare

Roots Analysis has announced the addition of the “Smart Wearables in Healthcare, 2016-2030” report to its list of offerings. The report provides a comprehensive analysis of the current market landscape with respect to key players and specific applications of the diverse range of... - October 03, 2016

HDAC Inhibitors: Controlling Disease Propagation by Regulating Gene Expression

Roots Analysis has announced the addition of the “HDAC Inhibitors Market, 2016-2026” report to their list of offerings. It provides a comprehensive study on the current landscape of the evolving pipeline in this area. With five commercialized products, the market has gained the... - September 19, 2016

Novel Drugs and Devices to Lower Intraocular Pressure: Revolutionary Advances Poised to Grow at a Rapid Rate

Roots Analysis has announced the addition of the “Novel Drugs and Devices to Lower Intraocular Pressure, 2016 - 2026” report to its list of offerings. The report provides a detailed study on the current market landscape, future trends and applications of these novel treatment options. - September 12, 2016

Non-Insulin Therapies for Diabetes: Growth Drivers and Future Outlook

Roots Analysis has announced the addition of “Non-Insulin Therapies for Diabetes: GLP-1 Agonists, DPP4 Inhibitors and SGLT2 Inhibitors, 2016 - 2026” report to its portfolio. The report provides a comprehensive analysis of the current market landscape of GLP-1 agonists, DPP4 inhibitors... - August 22, 2016

Vaccine Contract Manufacturing: a Niche Segment Poised to Become a Global Market by 2026

Roots Analysis has announced the addition of the “Vaccine Contract Manufacturing Market, 2016-2026” report to its list of offerings. The report provides an extensive study of the current market landscape, future trends and opportunities related to vaccine contract manufacturing. It... - July 12, 2016

Autoinjectors Market to Grow at 8% Annually, Predicts Roots Analysis

The "Global Autoinjectors Market, 2016-2026" report elaborates on self-administration devices, the origin/history of autoinjectors, their components and advantages offered by different categories of autoinjectors. - June 08, 2016

HPAPIs and Cytotoxic Drugs: The Growing Opportunity for Contract Manufacturers

Roots Analysis has announced the addition of HPAPIs and Cytotoxic Drugs Manufacturing Market, 2016-2026 (2nd edition) report to its portfolio. The report provides an extensive study of the contract manufacturing opportunity in this rapidly expanding market. The focus of this report is primarily to... - March 21, 2016

Specialty CROs: The Future of R&D Outsourcing

Roots Analysis has announced the addition of Specialty CROs Market, 2016-2025 report to their offering. The report delivers a comprehensive study on Contract Research Organizations (CROs) that offer specialized sets of research capabilities/services, focused on a particular stage of clinical... - March 07, 2016

Peptide Therapeutics: The Growing Hope for Metabolic Disorders

Roots Analysis has announced the addition of “Peptide Therapeutics in Metabolic Disorders, 2016-2025” report to its portfolio. The report provides a comprehensive study on the current market landscape and the future outlook of the evolving pipeline of peptide therapeutics that are being... - February 16, 2016

Microbiome Therapeutics Market: What’s the Future Potential?

The "Microbiome Therapeutics Market, 2015-2030" report provides a comprehensive study on the current landscape and the future outlook of the evolving pipeline of products in this area. - January 18, 2016

T-Cell Immunotherapy Market to be Worth USD 30 Billion by 2030, Predicts Roots Analysis

The “T-Cell Immunotherapy Market, 2015-2030” report provides an extensive study of the field of T-cell immunotherapy. With no marketed products, this emerging field is still in its infancy; the report provides a comprehensive view of the market segmented into the following three sub-groups: CAR-T therapies, TCR therapies and TIL therapies. - October 13, 2015

NASH Drugs Market, 2015-2025

The "NASH Drugs Market, 2015-2025" report provides a comprehensive study on the current landscape and the future outlook of the evolving pipeline of molecules in this area. With an expanding NAFLD and NASH population worldwide, there is a growing need for development of therapeutics in this disease area. - September 03, 2015

Protein Expression Systems Market: Current Landscape and Future Opportunities

Advances in genetic engineering and cloning techniques have allowed isolation and expression of heterologous and recombinant proteins for research, therapeutic and industrial uses. Large scale applications such as enzyme, antibody or vaccine production require high amounts of protein. This demands that the system producing protein must be easy to culture, allow rapid cell growth and provide good yield. - September 02, 2015

ADC Contract Manufacturing Market: Opportunities Ahead

Antibody Drug Conjugates (ADCs) are a new class of therapeutic drugs consisting of a cytotoxic drug linked to a monoclonal antibody. These novel conjugates are believed to be very effective and efficient in treatment of a disease. However, manufacturing such highly potent toxic molecules is accompanied with several known and unknown challenges. - August 10, 2015

Global Biosimilars Market, 2015-2025

Characterised by increased utility in chronic diseases and capital intensive manufacturing, the global biopharmaceutical market is expanding robustly. As the demand for biologics is increasing continuously, manufacturers are on the lookout for novel strategies that will help them attain maximum returns on investment. - July 22, 2015

Non-Tyrosine Kinase Inhibitors Market to Witness 9% Annualized Growth, Predicts Roots Analysis

Roots Analysis has announced the addition of “Non-Tyrosine Kinase Inhibitors in Oncology, 2015-2025” report to their offering. The report provides a comprehensive analysis of the current market landscape and the future outlook of kinase inhibitors not specifically targeting tyrosine... - July 16, 2015

Companion Diagnostics Market to Grow at 22.9% Over the Next Decade, Predicts Roots Analysis

Roots Analysis has announced the addition of “Companion Diagnostics Market, 2014 - 2024 (2nd edition)” report to their offering. The study offers an extensive analysis of this growing market, including market forecasts for the period 2014-2024. Shefali Asija, the principal analyst... - July 09, 2015

Pharmaceutical Anti-Counterfeiting Technologies Market

The problem of counterfeit products has been a common challenge to all the industries across the globe. Counterfeit drugs create substantial public health hazards and cause crucial safety concerns. This field has attracted several companies which have developed many technologies with an aim to prevent counterfeiting in the pharma industry. - July 06, 2015

Immune Checkpoint Inhibitors Market to Witness 24.1% Annualised Growth, Predicts Roots Analysis

Roots Analysis has announced the addition of "Immune Checkpoint Inhibitors Market - 2014 - 2024" report to their offering. The study offers a comprehensive view of the emerging market of CTLA-4, PD-1, PD-L1 and several novel immune checkpoint inhibitors (IDO-1, IDO-2, KIR, OX40, CD70,... - July 05, 2015

HPAPIs and Cytotoxic Drugs Manufacturing Market to Evolve Rapidly, Reports Roots Analysis

Roots Analysis has announced the addition of “HPAPIs and Cytotoxic Drugs Manufacturing Market” report to their portfolio. The report provides an extensive study of the contract manufacturing opportunity for this rapidly expanding market. It identifies various CMOs active in this space,... - July 04, 2015

Rare Diseases: Market Opportunities Predicted by Roots Analysis

The report provides a comprehensive study of the pipeline drugs being developed for rare diseases by several top pharmaceutical firms. - July 03, 2015

Prefilled Syringes Market, 2015-2025

Injectable drug delivery systems have traversed a long way from conventional syringes with vials to prefilled syringes, auto-injectors, pen injectors and needle free systems. These modern devices have become preferred devices for parenteral administration of drugs, mainly used for treatment of chronic conditions requiring patients to self-administer medication several times a week. - June 29, 2015

Antibody Drug Conjugates: Contract Manufacturing Market to Evolve Rapidly, Predicts Roots Analysis

Roots Analysis has announced addition of the “Antibody Drug Conjugates: Contract Manufacturing Market 2014-2024” report to their offering. The report provides an extensive study of the contract manufacturing opportunity for this emerging class of therapeutics. It identifies various CMOs... - June 28, 2015

Large Volume Wearable Injectors: from Conception to Reality

The focus of the latest edition is to provide a comprehensive analysis of the current state of the market, including detailed sales forecasts of these devices over the next ten years. - June 26, 2015

Gene Therapy Market to be Worth Over USD 10 Billion by 2025, Predicts Roots Analysis

The report contains detailed analysis of the Gene Therapy market and forecasts the demand of the market in the coming decade. - June 12, 2015

Press Releases 1 - 27 of 27